Vascular Biology |
From the Clinical Pharmacology Unit (Y., C.M.M., K.M.O., P.H., A.A., S.W., K.M.-P., M.J.A., I.B.W.), University of Cambridge, Addenbrookes Hospital, Cambridge; the Department of Cardiology (B.M., J.R.C.), University of Wales College of Medicine, Cardiff; and Trinity College (J.B.), Cambridge, UK.
Correspondence to Dr Yasmin, Clinical Pharmacology Unit, University of Cambridge, Addenbrookes Hospital Box 110, Cambridge CB2 2QQ, UK. E-mail my105{at}medschl.cam.ac.uk
Background Arterial stiffness is an important determinant of cardiovascular risk. Elastin is the main elastic component of the arterial wall and can be degraded by a number of enzymes including serine proteases and matrix metalloproteinases (MMPs). Serum MMP-9 levels correlate with arterial stiffness and predict cardiovascular risk. Polymorphisms in the MMP-9 gene are also associated with large artery function in subjects with coronary artery disease. Therefore, we investigated the influence of known MMP-9 (1562C>T, R279Q) polymorphisms on arterial stiffness in a large cohort of healthy individuals (n=865).
Methods and Results Aortic pulse wave velocity (PWV) and augmentation index were assessed. Supine blood pressure, biochemical markers, MMP-9 levels, and serum elastase activity (SEA) were also determined. Genomic DNA was extracted and genotyping performed. Aortic PWV, serum MMP-9, and SEA were higher in carriers of the rare alleles for the 1562C>T and R279Q polymorphisms. These polymorphisms were also associated with aortic PWV after correction for other confounding factors. Stepwise regression models with known or likely determinants of arterial stiffness revealed that
60% of the variability in aortic PWV was attributable to age, mean arterial pressure, and genetic variants (P<0.001).
Conclusions We have demonstrated for the first time that aortic stiffness and elastase activity are influenced by MMP-9 gene polymorphisms. This suggests that the genetic variation in this protein may be involved in the process of large artery stiffening.
We examined the influence of known MMP-9 polymorphisms on arterial stiffness and elastases in a large cohort of healthy individuals. Aortic stiffness and serum elastases are significantly influenced by MMP-9 polymorphisms, suggesting that genetic variation in this protein may be involved in the process of large artery stiffening.
Key Words: aortic pulse wave velocity augmentation index MMP-9 gene polymorphisms MMP-9 levels serum elastase activity
This article has been cited by other articles:
![]() |
I. S. Mackenzie, C. M. McEniery, Z. Dhakam, M. J. Brown, J. R. Cockcroft, and I. B. Wilkinson Comparison of the Effects of Antihypertensive Agents on Central Blood Pressure and Arterial Stiffness in Isolated Systolic Hypertension Hypertension, August 1, 2009; 54(2): 409 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Bolton, J. R Cockcroft, R. Sabit, M. Munnery, C. M McEniery, I. B Wilkinson, S. Ebrahim, J. E Gallacher, D. J Shale, and Y. Ben-Shlomo Lung function in mid-life compared with later life is a stronger predictor of arterial stiffness in men: The Caerphilly Prospective Study Int. J. Epidemiol., June 1, 2009; 38(3): 867 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dhingra, M. J. Pencina, P. Schrader, T. J. Wang, D. Levy, K. Pencina, D. A. Siwik, W. S. Colucci, E. J. Benjamin, and R. S. Vasan Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the Community Circulation, March 3, 2009; 119(8): 1101 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lacolley, P. Challande, M. Osborne-Pellegrin, and V. Regnault Genetics and pathophysiology of arterial stiffness Cardiovasc Res, March 1, 2009; 81(4): 637 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. MacNee, J. Maclay, and D. McAllister Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2008; 5(8): 824 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Wood and R. A. Stockley Editorial: Unifying the genetics, co-morbidities and management of COPD Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 113 - 117. [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |